Did Human Genome Sciences unfairly benefit from its political connections? According to a Los Angeles Times investigation, former Navy Secretary Richard Danzig talked up HGS' anthrax drug raxibacumab to his government contacts--at a time when he also served on the company's board. HGS scored some $334 million worth of government contracts for raxibacumab, which was its sole marketed product for years. The government remains the drug's only buyer, the Times says.